European Neuropsychopharmacology 2008-03-01

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

Tiziana Adage, Anne-Cécile Trillat, Anna Quattropani, Dominique Perrin, Laurent Cavarec, Jeffrey Shaw, Oxana Guerassimenko, Claudio Giachetti, Béatrice Gréco, Ilya Chumakov, Serge Halazy, Arthur Roach, Paola Zaratin

Index: Eur. Neuropsychopharmacol. 18(3) , 200-14, (2008)

Full Text: HTML

Abstract

Non-competitive N-methyl-d-aspartate (NMDA) blockers induce schizophrenic-like behavior in healthy volunteers and exacerbate symptomatology in schizophrenic patients. Hence, a compound able to enhance NMDA neurotransmission by increasing levels of d-serine, an endogenous full agonist at the glycine site of the NMDA receptors, could have anti-psychotic activity. One way to increase d-serine levels is the inhibition of d-amino acid oxidase (DAAO), the enzyme responsible for d-serine oxidation. Indeed AS057278, a potent in vitro (IC(50)=0.91 microM) and ex vivo (ED(50)=2.2-3.95 microM) DAAO inhibitor, was able to increase d-serine fraction in rat cortex and midbrain (10 mg/kg i.v.). AS057278 was able to normalize phencyclidine (PCP)-induced prepulse inhibition after acute (80 mg/kg) and chronic (20 mg/kg b.i.d.) oral administration in mice. Finally, AS057278 after oral chronic treatment (10 mg/kg b.i.d.) was able to normalize PCP-induced hyperlocomotion. These results suggest that AS057278 has the potential to anti-psychotic action toward both cognitive and positive symptoms of schizophrenia.


Related Compounds

  • 5-Methyl-1H-pyraz...

Related Articles:

Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.

2010-11-01

[Chirality 22 , 901-916, (2010)]

A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.

2011-01-01

[J. Pharmacol. Exp. Ther. 336 , 282-293, (2011)]

Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.

1982-11-01

[Diabetes 31(11) , 994-1001, (1982)]

Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.

2009-12-01

[Biochem. Pharmacol. 78(11) , 1360-5, (2009)]

[Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)].

1981-01-01

[Arzneimittelforschung 31(12) , 2096-100, (1981)]

More Articles...